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licenseH1N1 influenza: Is traditional Chinese medicine effective and safe?Influenza is a viral respiratory infection that causes an acute
febrile illness with myalgia, headache, and cough, and can
result in substantially elevated morbidity and mortality rates
during an epidemic.1 A novel influenza H1N1 infection began
in March 2009, which rapidly spread and caused the World
Health Organization to declare the first influenza pandemic
outbreak.2 The antiviral medication oseltamivir has been
approved for use against influenza H1N1 infections; however,
careful use of anti-influenza drugs has been recommended due
to the emergence of drug resistance and the side effects of
these drugs.3 Chinese herbal medicine, the most important
component of traditional Chinese medicine (TCM), has been
recommended for preventing and treating influenza due to the
limitations of healthcare resources in China. Shang-Han Lun
(Treatise of Exogenous Febrile Diseases or Discourse on Cold-
Damage Disorders) and Wen-Bing-Tiao-Bian (Detailed Anal-
ysis of Epidemic Warm Diseases) were regarded as the
seminal guidelines for treatment of influenza in TCM.4 In the
study of TCM, influenza is differentiated into two types: (1)
wind-cold syndrome and (2) wind-heat syndrome. Severe cold,
slight fever, absence of sweat, headache, aching pain of the
extremities, stuffy nose with nasal discharge, and cough with
thin sputum are the primary symptoms of the wind-cold type.
Alternatively, a high fever, slight aversion to cold, headache,
sore throat with congestion, and expectoration of yellowish
sputum are the main symptoms of the wind-heat type.5 Many
studies have shown that Chinese herbal medicine applied to
counter the effects of wind-cold or wind-heat types can inhibit
influenza virus, with some studies even showing potential
modulation of the cellular immune system in animals. For
example, Scutellaria baicalensis inhibits influenza HIN1 by
exerting cytotoxic activity against infected cells.6 Hypericum
perforatum L. could reduce the influenza HIN1 viral titer of
infected mice by modulation of inflammatory cytokines.7
However, evidence-based data regarding the therapeutic
effects and safety of TCM for treatment of influenza H1N1 in
humans remain unclear.
In 2013, Jiang et al8 assessed the therapeutic effects and
safety of Chinese herbal medicine as an alternative or
adjunctive therapy to other commonly used drugs for influenza
in 18 trials involving 2521 participants. They found in one
Chinese herbal trial that TCM is more effective than antiviralx.doi.org/10.1016/j.jcma.2015.12.002
901/Copyright © 2016, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).drugs in preventing or treating influenza, and the remaining 17
Chinese herbal trials indicated a similar effect as antiviral
drugs in preventing or treating influenza. However, the evi-
dence presented in these studies does not consequently support
or reject the use of any particular Chinese herbal preparations
for influenza because the included studies were of poor
quality. However, no obvious adverse events were reported in
the included studies. Furthermore, this meta-analysis did not
focus on the therapeutic effects and safety of Chinese herbal
medicine against the influenza H1N1 strain.
In this issue, Li9 analyzed the efficacy and safety of TCM
for treatment of influenza H1N1 in 30 trials including 3444
participants. In this study, the Jadad scale was used to evaluate
the quality of the clinical trials, and the results showed that
only three of those 30 clinical trials proved to be of high
quality. Participants who were treated by Chinese herbal
medicine had a shorter mean time of defervescence than the
control group. However, evidence did not support the propo-
sition that Chinese herbal medicine had a superior effective
rate and shortened duration of influenza H1N1 viral shedding
than the control group. Nonetheless, this result suggests that
Chinese herbal medicine might have comparatively better
potential effects on fever resolution than viral shedding in
influenza H1N1 infection. However, for participants who were
treated with integrated Chinese and Western medicines, the
duration of viral shedding was significantly reduced compared
with the control group. These data imply that integrated Chi-
nese and Western medicines (i.e., Chinese herbal medicine
plus oseltamivir) has beneficial anti-influenza H1N1 viral
effects. However, 18 studies in this meta-analysis described
the adverse effects of TCM, including nausea, vomiting,
diarrhea, abdominal pain, skin rashes, arrhythmia, and neu-
rological symptoms.
Although reports of two meta-analysis suggested that
Chinese herbal medicine appears to have a promising future in
the treatment of influenza H1N1, the low quality of Chinese
herbal trials is a major concern. Therefore, additional studies
are required that have demonstrated enhanced methodological
quality, substantially more participants, and good reporting to
provide stronger and more reliable evidence. Information
about Chinese herbal trials carried out for the treatment of
influenza H1N1 should be reported in detail according to thesevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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upon inclusion should be restricted, and laboratory tests
(routine blood tests, serum tests, or pathogenic examinations)
and chest X-rays should be conducted to define inclusion and
exclusion criteria, if available resources permit. The definition
of outcome measures and the incidence of adverse reactions
should be given due attention as well. Intervention in the
control group should be well-designed as a placebo, with no
prior treatment or the commonly used antiviral and anti-
pyreticeanalgesic drugs. Nonetheless, evidence remains
unpersuasive due to methodological limitations of many
existing Chinese herbal trials for the treatment of influenza
H1N1. Ultimately, more high-quality randomized clinical tri-
als with larger numbers of participants and clear reporting are
required to generate reliable results.
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